The SPDR S&P Biotech ETF (XBI) dropped 3.64% in regular trading Thursday but was up 0.21% after hours. The report highlights biotech after-hours gainers (including Werewolf Therapeutics), suggesting mixed near-term momentum despite the broad selloff earlier in the session.
The SPDR S&P Biotech ETF (XBI) dropped 3.64% in regular trading Thursday but was up 0.21% after hours. The report highlights biotech after-hours gainers (including Werewolf Therapeutics), suggesting mixed near-term momentum despite the broad selloff earlier in the session.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
